SCA
USNA icon

Secor Capital Advisors’s Usana Health Sciences USNA Stock Holding History

Secor Capital Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-58,832
Closed -$6.78M – 576
2018
Q2 		$6.78M Buy
58,832
+14,713
+33% +$1.61M 0.58% 29
2018
Q1 		$3.79M Sell
44,119
-2,954
-6% -$229K 0.31% 103
2017
Q4 		$3.49M Buy
47,073
+41,542
+751% +$2.78M 0.14% 118
2017
Q3 		$319K Buy
+5,531
New +$327K 0.03% 381
2015
Q3 		– Sell
-6,934
Closed -$474K – 613
2015
Q2 		$474K Buy
6,934
+1,652
+31% +$105K 0.17% 218
2015
Q1 		$293K Buy
+5,282
New +$271K 0.11% 318

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Secor Capital Advisors's USNA Position: Q3 2018 in Review

Secor Capital Advisors sold out of Usana Health Sciences (USNA) in Q3 2018, closing a stake of 58,832 shares — an estimated $6.78M sold.

Secor Capital Advisors first reported a position in USNA in Q1 2015 and held it in 6 quarters. The position peaked at $6.78M in Q2 2018. 197 funds tracked by Wall St. Rank hold USNA as of Q3 2018.

  • Secor Capital Advisors reported no remaining Usana Health Sciences position as of Q3 2018 after selling out during the quarter.
  • Secor Capital Advisors sold 58,832 Usana Health Sciences shares in Q3 2018, an estimated $6.78M.
  • Secor Capital Advisors first reported a position in Usana Health Sciences in Q1 2015 and held it in 6 quarters.
  • Secor Capital Advisors's Usana Health Sciences position peaked at $6.78M in Q2 2018.
  • 197 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2018.

Based on Secor Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.